Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2020
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Sars-CoV-2 vaccination strategy - Interim recommendations on the vaccination implementation modalities
2020
∙
ATAGI
Statement on the duration of observation after vaccination in the context of minimizing risk of exposure to COVID-19 at health care facilities
2020
∙
Sharon Greene, Blanche-Philomene Melanga Anya, H Asghar, Irtaza Chaudhri, S. Deblina Datta, Morgane Donadel, Koffi Isidore Kouadio, Shefer, Abigail, Kathleen Cavallaro
Strengthening National Immunization Technical Advisory Groups in resource-limited settings: current and potential linkages with polio national certification committees
2020
∙
SAGE
Summary of the WHO position on Rubella Vaccine
2020
∙
Nancy McClung, Mary Chamberland, Megan Wallace, Beth Bell, José Romero, Sara Oliver, Kathleen Dooling, Kathy Kinlaw, Dayna Bowen Matthew, Grace M. Lee, Keipp Talbot
The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine
2020
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine
2020
∙
Doran Fink
Update from the Vaccines and Related Biologics Products Advisory Committee (VRBPAC) Meeting of October 22, 2020
2020
∙
Megan Wallace, ACIP
Updates to COVID-19 Immunity and Epidemiology to Inform Vaccine Policy
2020
∙
Sarah Mbaeyi, ACIP
Use of mRNA COVID-19 Vaccines: Interim Clinical Considerations
2020
∙
ACIP, Sarah Mbaeyi
Use of Pfizer-BioNTech COVID-19 Vaccine: Clinical Considerations
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register